Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants:: Potential implication in relation to the pathogenesis of Parkinson's disease

被引:260
作者
Soto-Otero, R
Méndez-Alvarez, E
Hermida-Ameijeiras, A
Muñoz-Patiño, AM
Labandeira-Garcia, JL
机构
[1] Univ Santiago de Compostela, Fac Med, Dept Bioquim & Biol Mol, Grp Neuroquim, E-15705 Santiago De Compostela, Spain
[2] Univ Santiago de Compostela, Fac Med, Dept Ciencias Morfol, E-15705 Santiago De Compostela, Spain
关键词
6-hydroxydopamine; autoxidation; neurotoxicity; antioxidants; oxidative stress; Parkinson's disease;
D O I
10.1046/j.1471-4159.2000.0741605.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
6-Hydroxydopamine (6-OHDA) is a dopaminergic neurotoxin putatively involved in the pathogenesis of Parkinson's disease (PD). Its neurotoxicity has been related to the production of reactive oxygen species. In this study we examine the effects of the antioxidants ascorbic acid (AA), glutathione (GSH), cysteine (CySH), and N-acetyl-CySH (NAC) on the autoxidation and neurotoxicity of 6-OHDA. In vitro, the autoxidation of 6-OHDA proceeds rapidly with the formation of H2O2 and with the participation of the H2O2 produced in the reaction. The presence of AA induced a reduction in the consumption of O-2 during the autoxidation of 6-OHDA and a negligible presence of the p-quinone, which demonstrates the efficiency of AA to act as a redox cycling agent. The presence of GSH, CySH, and NAC produced a significant reduction in the autoxidation of 6-OHDA. In vivo, the presence of sulfhydryl antioxidants protected against neuronal degeneration in the striatum, which was particularly remarkable in the case of CySH and was attributed to its capacity to remove the H2O2 produced in the autoxidation of 6-OHDA. These results corroborate the involvement of oxidative stress as the major mechanism in the neurotoxicity of 6-OHDA and the putative role of CySH as a scavenger in relation to PD.
引用
收藏
页码:1605 / 1612
页数:8
相关论文
共 45 条
[21]  
Jellinger K, 1995, J NEURAL TRANSM-SUPP, P297
[22]   EFFECTS OF 6-HYDROXYDOPAMINE ON UPTAKE AND STORAGE OF NORADRENALINE IN SYMPATHETIC ADRENERGIC NEURONS [J].
JONSSON, G ;
SACHS, C .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1970, 9 (02) :141-&
[23]  
KUMAR R, 1995, J NEUROCHEM, V64, P1703
[24]   COMPETITIVE OXIDATION OF 6-HYDROXYDOPAMINE BY OXYGEN AND HYDROGEN-PEROXIDE [J].
LIANG, YO ;
WIGHTMAN, RM ;
ADAMS, RN .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1976, 36 (02) :455-458
[25]   ISOLATION AND IDENTIFICATION OF AN INVIVO REACTION-PRODUCT OF 6-HYDROXYDOPAMINE [J].
LIANG, YO ;
PLOTSKY, PM ;
ADAMS, RN .
JOURNAL OF MEDICINAL CHEMISTRY, 1977, 20 (04) :581-583
[26]   AUTORADIOGRAPHIC DEMONSTRAION OF UPTAKE AND ACCUMULATION OF H-3-6-HYDROXYDOPAMINE IN ADRENERGIC NERVES [J].
LJUNGDAHL, A ;
HOKFELT, T ;
JONSSON, G ;
SACHS, C .
EXPERIENTIA, 1971, 27 (03) :297-+
[27]  
Meister A, 1981, Methods Enzymol, V77, P237
[28]  
Méndez-Alvarez E, 1998, J APPL TOXICOL, V18, P443, DOI 10.1002/(SICI)1099-1263(199811/12)18:6<443::AID-JAT530>3.3.CO
[29]  
2-G
[30]   THE EFFECTS OF GLUTATHIONE AND ASCORBIC-ACID ON THE OXIDATIONS OF 6-HYDROXYDOPA AND 6-HYDROXYDOPAMINE [J].
NAPPI, AJ ;
VASS, E .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1994, 1201 (03) :498-504